STMicroelectronics N.V. (STM) Balance Sheet

Retained earnings held in a narrow $12.5B to $13.5B band, indicating that the cyclical earnings compression has not eroded the accumulated equity base. The recent asset rebound to $26.7B in 2026Q3 appears driven more by working capital and cash timing than by a structural expansion. Investors should monitor whether asset growth is matched by improving returns on the same capital base.

The low leverage profile suggests the company has not relied on borrowing to fund its heavy fab investment program, which warrants credit in a capital-intensive IDM model. The debt reduction from the 2026Q2 peak indicates active balance sheet management during the recovery. Refinancing risk appears limited on these figures, though the data does not disclose maturity schedules, so this conclusion remains provisional.

Cash balances fluctuated meaningfully, with the low of $1.6B in 2025Q2 representing the period of greatest pressure on the liquidity cushion. The current ratio's recovery to 3.13 in 2026Q3 suggests working capital has strengthened after the earlier trough. Given high capital expenditure requirements, investors should watch whether cash generation consistently covers fab spending without drawing down this buffer.

The PPE base remaining above $10.9B confirms the asset-heavy nature of the IDM model, where fab capacity drives both cost structure and competitive positioning. The goodwill reduction from roughly $700M to $315M warrants investigation, as the data alone does not reveal whether this reflects an impairment, a disposal, or an accounting change. Asset quality analysis would benefit from disclosure of fab utilization by node.

The disappearance of reported deferred revenue after 2025Q3 may indicate a change in contract structure, a reclassification, or a genuine reduction in advance customer commitments, and the supplied data does not allow these to be distinguished. A declining trend in prepayments generally signals weaker forward demand certainty for an industrial supplier. Investors should monitor order backlog disclosures to assess whether the recovery in revenue is supported by firm future orders.